Related Experiment Videos
Why do patients with atopic dermatitis refuse to apply topical corticosteroids?
1Department of Dermatology, National Nagoya Hospital, Nagoya City, Aichi Prefecture, Japan.
Dermatology (Basel, Switzerland)
|November 30, 2000
Summary
Patient reluctance to use topical corticosteroids stems from personal negative experiences, not external advice. Open communication with physicians about side effects can improve trust and treatment adherence for atopic dermatitis.
Area of Science:
- Dermatology
- Patient Psychology
Background:
- Increasing patient refusal of topical corticosteroids for atopic dermatitis due to personal fears.
- Limited existing research on the drivers of this treatment resistance.
Purpose of the Study:
- Investigate the reasons behind patient reluctance to use topical corticosteroids.
- Identify factors contributing to resistance in atopic dermatitis management.
Main Methods:
- Cross-sectional questionnaire-based study conducted in Japan (Sept 1998 - Jan 1999).
- Survey distributed to patients responding to announcements and those attending 18 hospitals/clinics and 11 self-help groups.
- Aimed to identify specific triggers for topical corticosteroid resistance.
Main Results:
- Key factors for reluctance include perceived ineffectiveness, adverse side effects, and physician distrust.
- Physician distrust was significantly higher in resistant patients.
- External influences (family, media, alternative therapists) showed no significant impact.
Conclusions:
- Patient resistance to topical corticosteroids is primarily driven by personal experiences, not external information.
- Physician-provided information on side effects can mitigate fears and enhance the doctor-patient relationship.
- Addressing patient concerns directly is crucial for improving adherence in atopic dermatitis treatment.